Efficacy
SD
DISEASE
Among the 13 patients enrolled in this study, one patient showed a partial response (PR) and 5 patients showed stable disease (SD) with an ORR of 7.7% (95% confidence interval [CI]: 0.2–36.0%) and a disease-control rate of 46.2% (95% CI: 19.2–74.9%) (Fig. Efficacy analyses of combination treatment with afatinib and osimertinib. (